MAZE - Company ID 0001842295
The table below shows Maze Therapeutics, Inc.'s balance sheet line items across its last 1 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 |
|---|---|
| Cash & equivalents | $189.25M |
| Short-term investments | $152.67M |
| Receivables | - |
| Inventory | - |
| Total current assets | $349.72M |
| Property, plant & equipment | $5.04M |
| Goodwill | - |
| Total assets | $397.13M |
| Accounts payable | $1.79M |
| Total current liabilities | $22.56M |
| Long-term debt | - |
| Total liabilities | $42.16M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Retained earnings |
| -$489.55M |
| Total equity | $354.97M |